Artiva Biotherapeutics Q1 EPS $(0.95) Misses $(0.89) Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings MissesNews
Artiva Biotherapeutics (NASDAQ:ARTV) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.89) by 6.74 percent. This is a 14.46 percent decrease over losses of $(0.83) per
Artiva Biotherapeutics (NASDAQ:ARTV) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.89) by 6.74 percent. This is a 14.46 percent decrease over losses of $(0.83) per share from the same period last year.